{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T18:26:05Z","timestamp":1767896765044,"version":"3.49.0"},"reference-count":21,"publisher":"FapUNIFESP (SciELO)","issue":"3A","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[2002,9]]},"abstract":"<jats:p>Acute headache is a very frequent symptom, responsible for a significant percentage of caseload at primary care units and emergency rooms. Chlorpromazine is easily available in such settings. The aim of this study is to conduct a randomized, placebo-controlled, double-blind study to assess the efficacy of chlorpromazine on the acute treatment of episodic tension-type headache. We randomized 30 patients to receive placebo (10 ml of saline intravenous injections) and 30 patients to receive 0.1 mg\/Kg chlorpromazine intravenously. We used 7 parameters of analgesic evaluation. Patients receiving chlorpromazine showed a statistically significant improvement (p &lt; 0.05 and p &lt; 0.01) of pain compared to placebo, far up to 30 minutes after the drug administration. The therapeutic gain was 36.7% in 30 minutes and 56.6 % in 60 minutes. The number needed to treat (NNT, the reciprocal or the therapeutic gain) was 2.7 in 30 minutes and 1.8 in 60 minutes. There were reductions in the recurrence and in the use of rescue medication in the chlorpromazine group. We can conclude that intravenous chlorpromazine is an effective drug to relief the pain in tension-type headache.<\/jats:p>","DOI":"10.1590\/s0004-282x2002000400004","type":"journal-article","created":{"date-parts":[[2005,4,15]],"date-time":"2005-04-15T14:32:51Z","timestamp":1113575571000},"page":"537-541","source":"Crossref","is-referenced-by-count":16,"title":["Intravenous chlorpromazine in the acute treatment of episodic tension-type headache: a randomized, placebo controlled, double-blind study"],"prefix":"10.1590","volume":"60","author":[{"given":"Marcelo Eduardo","family":"Bigal","sequence":"first","affiliation":[{"name":"University of S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Alberto","family":"Bordini","sequence":"additional","affiliation":[{"name":"University of S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Geraldo","family":"Speciali","sequence":"additional","affiliation":[{"name":"University of S\u00e3o Paulo,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1468-2982.1991.1103129.x","article-title":"A population-based analysis of the diagnostic criteria of the International Headache Society","volume":"11","author":"Rasmussen BK","year":"1991","journal-title":"Cephalalgia","ISSN":"https:\/\/id.crossref.org\/issn\/0333-1024","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1526-4610.2000.00035.x","article-title":"Etiology and distribution of headaches in two Brazilian primary care units","volume":"40","author":"Bigal ME","year":"2000","journal-title":"Headache","ISSN":"https:\/\/id.crossref.org\/issn\/0017-8748","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1590\/S1516-31802000000300002","article-title":"Headache in an emergency room in Brazil","volume":"118","author":"Bigal ME","year":"2000","journal-title":"S\u00e3o Paulo Medical Journal"},{"key":"ref4","series-title":"The pharmacologic basis of therapeutics","first-page":"654","author":"Goodman AG","year":"1980","edition":"6"},{"key":"ref5","series-title":"Principles of medical pharmacology","first-page":"123","author":"Seeman P","year":"1980","edition":"3"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(78)90193-9","article-title":"Mechanism of the antipsychotic agents: the treatment of acute schizophrenia","volume":"22","author":"Johnstone EC","year":"1978","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1468-2982.1998.1804174.x","article-title":"Dopamine and migraine: a review of pharmacological, biochemical, neurophysiological, and therapeutic data","volume":"18","author":"Mascia A","year":"1998","journal-title":"Cephalalgia","ISSN":"https:\/\/id.crossref.org\/issn\/0333-1024","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0196-0644(87)80569-3","article-title":"Treatment of migraine with intramuscular chlorpromazine","volume":"16","author":"McEwen JI","year":"1987","journal-title":"Ann Emerg Med","ISSN":"https:\/\/id.crossref.org\/issn\/0196-0644","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1590\/S0004-282X1998000400008","article-title":"Uso da clorpromazina para tratamento da cefal\u00e9ia no servi\u00e7o de emerg\u00eancia","volume":"56","author":"Costa AG","year":"1997","journal-title":"Arq Neuropsiquiatr","ISSN":"https:\/\/id.crossref.org\/issn\/0004-282X","issn-type":"print"},{"key":"ref10","first-page":"756","article-title":"Parenteral chlorpromazine treatment of migraine","volume":"16","author":"Iverson KV","year":"1983","journal-title":"Ann Emerg Med","ISSN":"https:\/\/id.crossref.org\/issn\/0196-0644","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1526-4610.1985.hed2506302.x","article-title":"Intravenous chlorpromazine: preliminary results in acute migraine","volume":"25","author":"Lane RL","year":"1985","journal-title":"Headache","ISSN":"https:\/\/id.crossref.org\/issn\/0017-8748","issn-type":"print"},{"key":"ref12","article-title":"Intravenous dipyrone in the acute treatment of migraine without aura and migraine with aura: evaluation of the analgesic effect of the drug, of its effect on associated symptoms and adverse events profile: A randomized, placebo controlled, blind study","author":"Bigal ME","journal-title":"Headache","ISSN":"https:\/\/id.crossref.org\/issn\/0017-8748","issn-type":"print"},{"key":"ref13","article-title":"Intravenous dipyrone in the acute treatment of tension-type headache: A randomized, placebo controlled, double-blind study","author":"Bigal ME","journal-title":"Cephalalgia","ISSN":"https:\/\/id.crossref.org\/issn\/0333-1024","issn-type":"print"},{"issue":"8","key":"ref14","first-page":"1","article-title":"Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain","year":"1988","journal-title":"Cephalalgia","ISSN":"https:\/\/id.crossref.org\/issn\/0333-1024","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jama.279.4.319","article-title":"The randomized controlled trial gets a middle-aged checkup","volume":"279","author":"Jadad AR","year":"1998","journal-title":"JAMA","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref16","first-page":"40","article-title":"Assessing headache severity: New directions","volume":"44","author":"Von-Korff M","year":"1994","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0196-0644(89)80570-0","article-title":"Comparative efficacy of chlorpromazine and meperidine with dimenydrate in migraine headache","volume":"18","author":"Lane PL","year":"1989","journal-title":"Ann Emerg Med","ISSN":"https:\/\/id.crossref.org\/issn\/0196-0644","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1526-4610.1990.hed3002085.x","article-title":"Response of non-migrainous headaches to chlorpromazine","volume":"30","author":"Barclay CL","year":"1990","journal-title":"Headache","ISSN":"https:\/\/id.crossref.org\/issn\/0017-8748","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1526-4610.1980.hed2003128.x","article-title":"Cluster headache: response to chlorpromazine","volume":"20","author":"Caviness VS","year":"1980","journal-title":"Headache","ISSN":"https:\/\/id.crossref.org\/issn\/0017-8748","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1468-2982.2000.00117.x","article-title":"Guidelines for controlled trials of drugs in migraine: second edition","volume":"20","author":"Tfelt--Hansen P","year":"2000","journal-title":"Cephalalgia","ISSN":"https:\/\/id.crossref.org\/issn\/0333-1024","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1526-4610.1985.hed2506302.x","article-title":"Intravenous chlorpromazine: preliminarly results in acute migraine","volume":"25","author":"Lane RL","year":"1985","journal-title":"Headache","ISSN":"https:\/\/id.crossref.org\/issn\/0017-8748","issn-type":"print"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v60n3a\/11121.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T21:58:22Z","timestamp":1495663102000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2002000400004&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":21,"journal-issue":{"issue":"3A","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["S0004-282X2002000400004"],"URL":"https:\/\/doi.org\/10.1590\/s0004-282x2002000400004","relation":{},"ISSN":["0004-282X"],"issn-type":[{"value":"0004-282X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,9]]}}}